These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 7680623)

  • 1. Mutagenesis and chemical cross-linking suggest that Wzz dimer stability and oligomerization affect lipopolysaccharide O-antigen modal chain length control.
    Papadopoulos M; Morona R
    J Bacteriol; 2010 Jul; 192(13):3385-93. PubMed ID: 20453100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the O-specific lipopolysaccharide biosynthesis region (rfb) of Escherichia coli K-12 W3110: identification of genes that confer group 6 specificity to Shigella flexneri serotypes Y and 4a.
    Yao Z; Valvano MA
    J Bacteriol; 1994 Jul; 176(13):4133-43. PubMed ID: 7517390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation of O-specific lipopolysaccharides from Shigella flexneri 3a and 2a occurs in Escherichia coli K-12 carrying cloned S. flexneri 3a and 2a rfb genes.
    Yao Z; Liu H; Valvano MA
    J Bacteriol; 1992 Dec; 174(23):7500-8. PubMed ID: 1280255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
    Fält IC; Schweda EK; Klee S; Singh M; Floderus E; Timmis KN; Lindberg AA
    J Bacteriol; 1995 Sep; 177(18):5310-5. PubMed ID: 7545156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella flexneri.
    Morona R; van den Bosch L; Manning PA
    J Bacteriol; 1995 Feb; 177(4):1059-68. PubMed ID: 7532168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a lipopolysaccharide encoded by a recombinant Shigella sonnei plasmid in Escherichia coli K-12.
    Seltmann G; Knirel YA; Shashkov AS; Tschäpe H
    Zentralbl Bakteriol; 1992 Dec; 277(4):419-28. PubMed ID: 1284653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biosynthetic aspects of Shigella flexneri O-specific lipopolysaccharides.
    Simmons DA
    Biochem Soc Trans; 1993 Feb; 21(1):58S. PubMed ID: 7680623
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure and biology of Shigella flexneri O antigens.
    Simmons DA; Romanowska E
    J Med Microbiol; 1987 Jun; 23(4):289-302. PubMed ID: 2438412
    [No Abstract]   [Full Text] [Related]  

  • 9. Shigella lipopolysaccharide: structure, genetics, and vaccine development.
    Brahmbhatt HN; Lindberg AA; Timmis KN
    Curr Top Microbiol Immunol; 1992; 180():45-64. PubMed ID: 1380416
    [No Abstract]   [Full Text] [Related]  

  • 10. O-antigen modifications providing antigenic diversity of Shigella flexneri and underlying genetic mechanisms.
    Knirel YA; Sun Q; Senchenkova SN; Perepelov AV; Shashkov AS; Xu J
    Biochemistry (Mosc); 2015 Jul; 80(7):901-14. PubMed ID: 26542003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri.
    Allison GE; Verma NK
    Trends Microbiol; 2000 Jan; 8(1):17-23. PubMed ID: 10637639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.